26 related articles for article (PubMed ID: 10809390)
1. Comparison of the biological properties of two anti-mucin-1 antibodies prepared for imaging and therapy.
Pietersz GA; Wenjun L; Krauer K; Baker T; Wreschner D; McKenzie IF
Cancer Immunol Immunother; 1997 Aug; 44(6):323-8. PubMed ID: 9298934
[TBL] [Abstract][Full Text] [Related]
2. Raising the Bar On-Bead: Efficient On-Resin Synthesis of α-Conotoxin LvIA.
Kondasinghe TD; Saraha HY; Jackowski ST; Stockdill JL
Tetrahedron Lett; 2019 Jan; 60(1):23-28. PubMed ID: 31564757
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and immunological studies of alpha-conotoxin chimera containing an immunodominant epitope from the 268-284 region of HSV gD protein.
Mezo G; Drakopoulou E; Paál V; Rajnavölgyi E; Vita C; Hudecz F
J Pept Res; 2000 Jan; 55(1):7-17. PubMed ID: 10667856
[TBL] [Abstract][Full Text] [Related]
4. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
[TBL] [Abstract][Full Text] [Related]
5. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibody recognition of synthetic antigens from MUC1.
Bánóczi Z; Mezõ G; Windberg E; Uray K; Majer Z; Hudecz F
J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847
[TBL] [Abstract][Full Text] [Related]
7. Stability and structure-forming properties of the two disulfide bonds of alpha-conotoxin GI.
Kaerner A; Rabenstein DL
Biochemistry; 1999 Apr; 38(17):5459-70. PubMed ID: 10220333
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibody recognition of mucin 1 (MUC1)-alpha-conotoxin chimera.
Drakopoulou E; Uray K; Mezö G; Price MR; Vita C; Hudecz F
J Pept Sci; 2000 Apr; 6(4):175-85. PubMed ID: 10809390
[TBL] [Abstract][Full Text] [Related]
9. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
[TBL] [Abstract][Full Text] [Related]
10. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
11. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.
Zhou D; Xu L; Huang W; Tonn T
Molecules; 2018 May; 23(6):. PubMed ID: 29857542
[TBL] [Abstract][Full Text] [Related]
12. Alteration of immunogenicity and antibody recognition of B-cell epitopes by synthetic branched chain polypeptide carriers with poly[L-lysine] backbone.
Hudecz F
Biomed Pept Proteins Nucleic Acids; 1995; 1(4):213-20. PubMed ID: 9346834
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
